← Browse by Condition
Medical Condition
crc
Total Trials
4
Recruiting Now
4
Trial Phases
Phase 1, Phase 2, Phase 1
NCT07204574 Phase 1, Phase 2
Recruiting
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
Enrollment
40 pts
Location
Taiwan
Sponsor
Chang Gung Memorial Hospital
NCT07349537 Phase 1
Recruiting
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
Enrollment
574 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT06445062 Phase 1, Phase 2
Recruiting
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
Enrollment
1,130 pts
Location
United States
Sponsor
Revolution Medicines, Inc.
NCT07321106 Phase 1
Recruiting
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer
Enrollment
80 pts
Location
United States
Sponsor
Cartography Biosciences